Stillwater Capital Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,603
Closed -$208K 73
2024
Q3
$208K Buy
+3,603
New +$195K 0.03% 71
2023
Q4
Sell
-3,920
Closed -$210K 73
2023
Q3
$210K Hold
3,920
0.04% 68
2023
Q2
$211K Hold
3,920
0.04% 70
2023
Q1
$213K Buy
+3,920
New +$191K 0.04% 68
2022
Q2
Sell
-3,920
Closed -$201K 80
2022
Q1
$201K Buy
+3,920
New +$202K 0.03% 74

Other funds holding SNY

Stillwater Capital Advisors's SNY Position: Q4 2024 in Review

Stillwater Capital Advisors sold out of Sanofi (SNY) in Q4 2024, closing a stake of 3,603 shares — an estimated $208K sold.

Stillwater Capital Advisors first reported a position in SNY in Q1 2022 and held it in 5 quarters. The position peaked at $213K in Q1 2023. 732 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • Stillwater Capital Advisors reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
  • Stillwater Capital Advisors sold 3,603 Sanofi shares in Q4 2024, an estimated $208K.
  • Stillwater Capital Advisors first reported a position in Sanofi in Q1 2022 and held it in 5 quarters.
  • Stillwater Capital Advisors's Sanofi position peaked at $213K in Q1 2023.
  • 732 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Stillwater Capital Advisors's 13F filing for Q4 2024, filed 16 Jan 2025.